P1226: BTG2, A NOVEL TARGET OF MIR-17-92, REGULATES B CELL RECEPTOR SIGNALING IN MANTLE CELL LYMPHOMA

• Yuka Kawaji-Kanayama,
• Taku Tsukamoto,
• Masakazu Nakano,
• Yuichi Tokuda,
• Hiroaki Nagata,
• Kentaro Mizuhara,
• Yoko Katsuragawa-Taminishi,
• Reiko Isa,
• Takahiro Fujino,
• Yayoi Matsumura-Kimoto,
• Shinsuke Mizutani,
• Yuji Shimura,
• Masafumi Taniwaki,
• Kei Tashiro,
• Junya Kuroda

Affiliations

Yuka Kawaji-Kanayama

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Taku Tsukamoto

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Masakazu Nakano

2 Kyoto Prefectural University of Medicine, Department of Genomic Medical Sciences, Kyoto, Japan

Yuichi Tokuda

2 Kyoto Prefectural University of Medicine, Department of Genomic Medical Sciences, Kyoto, Japan

Hiroaki Nagata

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Kentaro Mizuhara

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Yoko Katsuragawa-Taminishi

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Reiko Isa

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Takahiro Fujino

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Yayoi Matsumura-Kimoto

3 Japan Community Health care Organization, Kyoto Kuramaguchi Medical Center, Department of Hematology, Kyoto, Japan

Shinsuke Mizutani

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Yuji Shimura

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan

Masafumi Taniwaki

4 Kyoto Prefectural University of Medicine, Center for Molecular Diagnostic and Therapeutics, Kyoto, Japan

Kei Tashiro

2 Kyoto Prefectural University of Medicine, Department of Genomic Medical Sciences, Kyoto, Japan

Junya Kuroda

1 Kyoto Prefectural University of Medicine, Division of Hematology and Oncology, Department of Medicine, Kyoto, Japan